Clinical Trials Logo

Cervical Cancer clinical trials

View clinical trials related to Cervical Cancer.

Filter by:

NCT ID: NCT00513123 Completed - Cervical Cancer Clinical Trials

Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia

Start date: September 2002
Phase: N/A
Study type: Observational

The overall objective of this study is to identify potential improvements for a noninvasive method of diagnosing dysplasia and neoplasia in the cervix using digital colposcopy for colposcopy for fluorescence spectroscopy. Other Objectives: - To measure digital fluorescence and reflectance images in vivo of sites in the human cervix. - To evaluate the effect of acetic acid in the image contrast obtained. - Compare the device performance to colposcopy and pathologic analysis of tissue removed at colposcopy.

NCT ID: NCT00512551 Completed - Cervical Cancer Clinical Trials

DNA Array Analysis of Patients With Cervical Cancer

Start date: June 20, 2000
Phase: N/A
Study type: Observational

The goal of this clinical research study is to find out if the expression of certain genes is linked with the response of cervical cancer to radiation. Researchers will study a large number of genes located in tumor material to learn this information.

NCT ID: NCT00511615 Completed - Cervical Cancer Clinical Trials

Molecular Imaging for Detection of Cervical Intraepithelial Neoplasia

Start date: March 2005
Phase: N/A
Study type: Observational

The hypothesis of this research project is that topical application of the anti-EGFR or anti-E6/E7 contrast agents followed by optical imaging will yield images that reflect spatial variations in expression that correlate with the presence of cervical precancer. To gather feasibility data the investigators will: 1. Obtain cervical specimens from women with high grade squamous intraepithelial lesions (HGSILs) being treated with the loop electrosurgical excision procedure (LEEP). 2. After Loop Electrosurgical Excision Procedure (LEEP) is performed, obtain low and high resolution optical images before and after applying contrast agents topically to the epithelial surface of the tissue for 30 minutes before rinsing. 3. Submit the specimen for histology, and have it sectioned and stained using both H&E and immunohistochemical staining for EGFR or E6/E7. The images will be reconstructed into a two dimensional map delineating areas of Cervical Intraepithelial Neoplasia (CIN) and of EGFR or E6/E7 overexpression. Maps of the pathology will be compared to those obtained from the intact cervix exposed to the contrast agent.

NCT ID: NCT00508703 Completed - Cervical Cancer Clinical Trials

Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy

Start date: March 5, 2003
Phase: N/A
Study type: Observational

The goal of this clinical research study is to use CT scans to find any changes in position of the vagina and pelvic lymph node areas during the course of IMRT radiation therapy. Treatment can then be adjusted in order to "spare" as much normal tissue as possible during radiation therapy. Another goal is to study the side effects of IMRT radiation therapy.

NCT ID: NCT00506376 Completed - Cervical Cancer Clinical Trials

Simple Versus Radical Hysterectomy for Stage I Cervical Cancer

Start date: January 2003
Phase: N/A
Study type: Observational

The primary objective of this study is to assess the preferences (values and utilities) of women for complications and recurrences associated with the surgical treatment of cervical cancer. A secondary objective of this study is to compare the preferences of women at high-risk for developing cervix cancer with the preferences of women who have already been diagnosed with cervix cancer.

NCT ID: NCT00505726 Completed - Cervical Cancer Clinical Trials

Reflectance Confocal Imaging in Cervical Cancer Patients

Start date: November 2001
Phase: Phase 1
Study type: Observational

The goal of this clinical research study is to see if reflectance confocal microscopy works as well as standard methods to detect cancer of the cervix or precancerous lesions. Primary Objectives: 1. To identify potential clinical advantages for a noninvasive method of diagnosing dysplasia and neoplasia in the cervix using reflectance confocal microscopy. 2. To obtain real time reflected light images in vivo of sites in the human cervix. 3. To access the effects of acetic acid as a contrast agent for in vivo reflectance confocal imaging. 4. Evaluate the depth of penetration for the fiber optic confocal device and analyze the diagnostic value of images taken from different depths. 5. Determine the sensitivity and specificity of this device for the diagnosis of CIN.

NCT ID: NCT00501137 Completed - Cervical Cancer Clinical Trials

A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine

BCGov-01
Start date: July 2007
Phase: Phase 3
Study type: Interventional

Primary objective is to determine if antibody responses to HPV types 16 & 18 are non-inferior after a 2-dose paediatric regimen as compared to a 3-dose adult regimen of Q-HPV vaccination, with responses measured at Month 7.

NCT ID: NCT00500435 Completed - Cervical Cancer Clinical Trials

Extraperitoneal Lymph Node Dissection in Patients With Cervical Cancer

Start date: October 2003
Phase: N/A
Study type: Observational

Primary Objectives: - To determine the feasibility of performing an extraperitoneal laparoscopic lymphadenectomy in patients with stage IB2-IVA cervical carcinoma who are dispositioned to undergo radiotherapy and concurrent chemotherapy. - To document intraoperative and postoperative complications in patients undergoing extraperitoneal laparoscopic lymphadenectomy. - To determine the rate of lymph node metastases in the para-aortic region in patients with stage IB2-IVA cervical cancer. - To correlate histopathological findings in the para-aortic lymph nodes with preoperative imaging studies (Positron emission tomography (PET) and magnetic resonance imaging (MRI) and computed tomography (CT)).

NCT ID: NCT00483288 Completed - Cervical Cancer Clinical Trials

Written Educational Information and Phone Calls in Increasing Follow-Up Care in Hispanic Women With Abnormal Pap Smears

Start date: May 2005
Phase: N/A
Study type: Interventional

RATIONALE: Written educational materials and counseling by phone may help promote follow-up care in women with abnormal Pap smears. PURPOSE: This clinical trial is studying how well written educational information and phone calls work in increasing follow-up care in Hispanic women with abnormal Pap smears.

NCT ID: NCT00479375 Completed - Cervical Cancer Clinical Trials

Randomized Controlled Trial of Human Papillomavirus Testing in Primary Cervical Cancer Screening

SWEDESCREEN
Start date: May 1997
Phase: N/A
Study type: Interventional

Human papillomavirus (HPV)-based cervical screening is known to increase sensitivity for detection of high-grade cervical intraepithelial neoplasia (CIN). Randomized trials of longitudinal efficacy are required to assess whether these gains represent overdiagnosis or a protective effect. Methods: A total of 12527 women, aged 32-38, attending population-based invitational screening in Sweden were randomized 1:1 to HPV test and cytology (intervention arm) or cytology only (control arm). HPV-positive women were invited for a second HPV test at least one year later and women with type-specific persistent infections were then invited to colposcopy. A similar number of random double-blinded procedures are performed in the control arm. Women are followed with comprehensive registry-based follow-up. Primary outcome is the relative rates of CIN grade 2 or worse (CIN2/CIN3+) found in subsequent screening. Secondary outcomes are the relative rates of CIN2/CIN3+ found in the aseline screening and outcomes stratified by grade of CIN (CIN 2 or CIN3+).